Related Experiment Videos
The A1555G mtDNA mutation in Danish hearing-impaired patients: frequency and clinical signs
E ØStergaard1, B Montserrat-Sentis, K Grønskov
1Department of Medical Genetics, The John F. Kennedy Institute, Glostrup, Denmark. els@kennedy.dk
Abstract:
The A1555G mutation of the mtDNA is associated with both aminoglycoside-induced and non-syndromic hearing loss. The A1555G is relatively frequent in the Spanish and some Asian populations, but has only been reported rarely in other populations, possibly because of ascertainment bias. We studied 85 Danish patients with varying degrees of hearing impairment and found two patients with the A1555G mutation (2.4%). Neither had received aminoglycosides. Our study indicates that the mutation might not be uncommon in Danish patients with hearing impairment.
Insights
The mitochondrial DNA A1555G mutation is linked to hearing loss. This study found the mutation in 2.4% of Danish patients, suggesting it may be more common than previously thought in this population.
Area of Science:
- Genetics
- Otolaryngology
- Mitochondrial Biology
Background:
- The mitochondrial DNA (mtDNA) A1555G mutation is a known cause of aminoglycoside-induced and non-syndromic hearing loss.
- This mutation is prevalent in Spanish and some Asian populations but rarely reported elsewhere, potentially due to ascertainment bias.
Purpose of the Study:
- To investigate the prevalence of the A1555G mutation in Danish patients with hearing impairment.
- To determine if the mutation occurs in individuals without a history of aminoglycoside exposure.
Main Methods:
- Genetic analysis of mitochondrial DNA (mtDNA) was performed.
- 85 Danish patients with varying degrees of hearing impairment were screened for the A1555G mutation.
Main Results:
- Two out of 85 Danish patients (2.4%) were found to carry the A1555G mutation.
- Neither of the patients with the mutation had a history of aminoglycoside use.
Conclusions:
- The A1555G mutation may not be uncommon in Danish patients presenting with hearing impairment.
- These findings suggest a potential role for the A1555G mutation in non-syndromic hearing loss within the Danish population, independent of aminoglycoside exposure.